Table 2 Overall and institution type specific odds of admittance to SPC for Danish cancer patients, mutually adjusted

Sex

(P < 0.001)

(P < 0.033)

(P < 0.001)

(P < 0.001)

 Women

1.23 (1.17–1.28)

1.06 (1.00–1.11)

1.45 (1.37–1.54)

1.34 (1.23–1.47)

 Men

1 (ref)

1 (ref)

1 (ref)

1 (ref)

Age (years)

(P < 0.001)

(P < 0.001)

(P < 0.001)

(P < 0.001)

 18–39

6.44 (5.19–7.99)

6.81 (5.53–8.38)

3.17 (2.54–3.97)

6.73 (5.08–8.93)

 40–49

4.60 (4.09–5.18)

4.80 (4.26–5.41)

2.90 (2.54–3.31)

5.64 (4.72–6.74)

 50–59

3.22 (3.00–3.47)

3.48 (3.22–3.76)

2.13 (1.94–2.32)

3.63 (3.16–4.17)

 60–69

2.46 (2.32–2.60)

2.56 (2.41–2.73)

1.89 (1.76–2.03)

2.80 (2.49–3.16)

 70–79

1.80 (1.70–1.89)

1.86 (1.75–1.97)

1.52 (1.42–1.64)

1.97 (1.74–2.22)

 80+

1 (ref)

1 (ref)

1 (ref)

1 (ref)

Diagnosis (cancer site)

(P < 0.001)

(P < 0.001)

(P < 0.001)

(P < 0.001)

 Oral cavity, nasopharyngeal (etc.) (C00–C14)

0.95 (0.83–1.09)

1.07 (0.93–1.23)

0.94 (0.79–1.12)

1.23 (0.97–1.55)

 Oesophageal (C15)

1.34 (1.18–1.52)

1.36 (1.19–1.56)

1.09 (0.93–1.29)

1.08 (0.85–1.38)

 Stomach (C16)

1.69 (1.50–1.90)

1.63 (1.44–1.85)

1.50 (1.30–1.73)

1.67 (1.37–2.04)

 Small intestine (C17)

1.23 (0.89–1.68)

1.34 (0.96–1.87)

1.07 (0.72–1.59)

1.31 (0.75–2.29)

 Colorectal (C18–C20)

1.13 (1.05–1.22)

1.16 (1.07–1.26)

1.09 (0.99–1.19)

1.18 (1.03–1.35)

 Liver (etc.) (C22)

0.92 (0.80–1.07)

0.91 (0.77–1.07)

0.83 (0.68–1.02)

0.59 (0.42–0.84)

 Pancreatic (C25)

1.77 (1.61–1.94)

1.59 (1.44–1.75)

1.47 (1.31–1.64)

1.31 (1.11–1.54)

 Laryngeal (C32)

0.75 (0.58–0.97)

0.82 (0.62–1.08)

0.80 (0.57–1.13)

0.93 (0.57–1.53)

 Tracheal, bronchial and lung (C33–C34)

1.16 (1.09–1.23)

1.15 (1.07–1.23)

1.12 (1.03–1.21)

1.12 (1.00–1.25)

 Melanoma skin cancer (C43)

1.46 (1.26–1.69)

1.31 (1.12–1.54)

1.52 (1.28–1.81)

1.53 (1.19–1.96)

 Sarcoma (C46–C49)

1.90 (1.52–2.38)

1.74 (1.39–2.19)

1.54 (1.20–1.98)

1.58 (1.12–2.23)

 Breast (C50)

0.96 (0.88–1.05)

0.99 (0.90–1.09)

0.94 (0.84–1.04)

0.93 (0.79–1.08)

 Cervical (C53)

1.10 (0.87–1.39)

1.06 (0.83–1.36)

1.30 (1.00–1.69)

1.43 (1.01–2.03)

 Uterine (C54–55)

1.35 (1.13–1.62)

1.36 (1.11–1.66)

1.16 (0.93–1.45)

1.15 (0.82–1.62)

 Ovarian (etc.) (C56,C570–C574)

1.57 (1.38–1.78)

1.38 (1.20–1.58)

1.56 (1.35–1.80)

1.52 (1.23–1.86)

 Prostate (C61)

1.32 (1.21–1.44)

1.54 (1.40–1.69)

1.04 (0.93–1.18)

1.58 (1.34–1.87)

 Testicular (C62)

0.50 (0.26–0.99)

0.68 (0.34–1.37)

0.63 (0.25–1.56)

1.11 (0.40–3.06)

 Kidney (etc.) (C64–C66)

1.46 (1.28–1.66)

1.49 (1.30–1.71)

1.19 (1.01–1.40)

1.28 (1.01–1.63)

 Bladder (C67)

1.04 (0.92–1.17)

1.13 (0.99–1.29)

0.92 (0.78–1.08)

1.06 (0.83–1.35)

 Brain/CNS (C70–C71, C751–C753)^a

1.05 (0.98–1.17)

0.85 (0.75–0.97)

1.30 (1.13–1.49)

0.97 (0.78–1.20)

 Thyroid (C73)

1.54 (1.07–2.22)

1.49 (1.01–2.20)

1.29 (0.83–2.00)

1.25 (0.64–2.43)

 Unknown primary cancer (C76–C80)

0.93 (0.83–1.04)

0.89 (0.79–1.00)

0.99 (0.86–1.13)

0.86 (0.69–1.07)

 Hodgkin disease (C81)

0.33 (0.17–0.63)

0.37 (0.18–0.77)

0.52 (0.23–1.17)

0.65 (0.21–2.03)

 Non-Hodgkin lymphoma (C82–C85)

0.49 (0.42–0.60)

0.41 (0.33–0.51)

0.70 (0.56–0.87)

0.50 (0.33–0.74)

 Multiple myeloma (C 90)

0.50 (0.42–0.61)

0.52 (0.42–0.65)

0.55 (0.42–0.72)

0.46 (0.28–0.73)

 Leukemia (C91–C95)

0.34 (0.29–0.40)

0.29 (0.23–0.35)

0.47 (0.38–0.58)

0.18 (0.10–0.30)

 Other cancer (all other C codes)

0.91 (0.83–1.00)

0.96 (0.87–1.07)

0.90 (0,80–1,02)

0.99 (0,83–1,19)

 Average of all diagnoses

1 (ref)

1 (ref)

1 (ref)

1 (ref)